V BRYAN LAWLIS Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for V BRYAN LAWLIS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of V BRYAN LAWLIS. V BRYAN LAWLIS is President in ARADIGM CORP ($ARDM) and Director in GERON CORP ($GERN) and Director in BIOMARIN PHARMACEUTICAL INC ($BMRN) and Director in SUTRO BIOPHARMA INC ($STRO) and Director in Coherus BioSciences, Inc. ($CHRS) and Director in Aeglea BioTherapeutics, Inc. ($AGLE).
Latest Insider Trading Transactions of V BRYAN LAWLIS
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGLE, ARDM, BMRN, CHRS, GERN, STRO
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 27 2021 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Grant | A | 0.00 | 5,120 | 0 | 23,970 | 18.9 K to 24 K (+27.16 %) |
May 13 2021 | GERN | GERON CORP | LAWLIS V BRYAN | Director | Option Exercise | A | 1.39 | 83,000 | 115,370 | 83,000 | |
Apr 19 2021 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Option Exercise | M | 26.49 | 7,500 | 198,675 | 0 | |
Apr 19 2021 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Sell | S | 76.90 | 7,500 | 576,750 | 18,850 | 26.4 K to 18.9 K (-28.46 %) |
Apr 19 2021 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Buy | M | 26.49 | 7,500 | 198,675 | 26,350 | 18.9 K to 26.4 K (+39.79 %) |
Jan 13 2021 | CHRS | Coherus BioScience ... | LAWLIS V BRYAN | Director | Option Exercise | A | 17.58 | 20,000 | 351,600 | 20,000 | |
Jun 10 2020 | AGLE | Aeglea BioTherapeu ... | LAWLIS V BRYAN | Director | Option Exercise | A | 8.89 | 28,100 | 249,809 | 28,100 | |
Jun 09 2020 | GERN | GERON CORP | LAWLIS V BRYAN | Director | Option Exercise | A | 1.54 | 83,000 | 127,820 | 83,000 | |
Jun 09 2020 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Sell | S | 107.46 | 4,430 | 476,048 | 18,850 | 23.3 K to 18.9 K (-19.03 %) |
May 29 2020 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Grant | A | 0.00 | 4,300 | 0 | 23,280 | 19 K to 23.3 K (+22.66 %) |
Mar 18 2020 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Option Exercise | M | 21.51 | 3,750 | 80,663 | 0 | |
Mar 18 2020 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Sell | S | 75.39 | 3,750 | 282,713 | 18,980 | 22.7 K to 19 K (-16.50 %) |
Mar 18 2020 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Buy | M | 21.51 | 3,750 | 80,663 | 22,730 | 19 K to 22.7 K (+19.76 %) |
Mar 18 2020 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Sell | S | 76.52 | 4,610 | 352,757 | 18,980 | 23.6 K to 19 K (-19.54 %) |
Jan 14 2020 | CHRS | Coherus BioScience ... | LAWLIS V BRYAN | Director | Option Exercise | A | 17.73 | 20,000 | 354,600 | 20,000 | |
Dec 19 2019 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Option Exercise | M | 21.51 | 3,750 | 80,663 | 3,750 | |
Dec 19 2019 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Sell | S | 83.36 | 3,750 | 312,600 | 23,590 | 27.3 K to 23.6 K (-13.72 %) |
Dec 19 2019 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Buy | M | 21.51 | 3,750 | 80,663 | 27,340 | 23.6 K to 27.3 K (+15.90 %) |
Sep 18 2019 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Option Exercise | M | 21.51 | 3,750 | 80,663 | 7,500 | |
Sep 18 2019 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Sell | S | 74.47 | 3,750 | 279,263 | 23,590 | 27.3 K to 23.6 K (-13.72 %) |
Sep 18 2019 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Buy | M | 21.51 | 3,750 | 80,663 | 27,340 | 23.6 K to 27.3 K (+15.90 %) |
Jun 19 2019 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Option Exercise | M | 21.51 | 3,750 | 80,663 | 11,250 | |
Jun 19 2019 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Sell | S | 81.08 | 3,750 | 304,050 | 23,590 | 27.3 K to 23.6 K (-13.72 %) |
Jun 19 2019 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Buy | M | 21.51 | 3,750 | 80,663 | 27,340 | 23.6 K to 27.3 K (+15.90 %) |
Jun 07 2019 | GERN | GERON CORP | LAWLIS V BRYAN | Director | Option Exercise | A | 1.38 | 70,000 | 96,600 | 70,000 | |
Jun 07 2019 | AGLE | Aeglea BioTherapeu ... | LAWLIS V BRYAN | Director | Option Exercise | A | 6.33 | 12,400 | 78,492 | 12,400 | |
Jun 07 2019 | AGLE | Aeglea BioTherapeu ... | LAWLIS V BRYAN | Director | Option Exercise | A | 6.33 | 12,400 | 78,492 | 12,400 | |
Jun 06 2019 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Grant | A | 0.00 | 4,430 | 0 | 23,590 | 19.2 K to 23.6 K (+23.12 %) |
Mar 29 2019 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Option Exercise | M | 14.39 | 2,150 | 30,939 | 0 | |
Mar 29 2019 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Sell | S | 89.76 | 2,150 | 192,984 | 19,160 | 21.3 K to 19.2 K (-10.09 %) |
Mar 29 2019 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Buy | M | 14.39 | 2,150 | 30,939 | 21,310 | 19.2 K to 21.3 K (+11.22 %) |
Jan 30 2019 | CHRS | Coherus BioScience ... | LAWLIS V BRYAN | Director | Option Exercise | A | 12.37 | 20,000 | 247,400 | 20,000 | |
Dec 28 2018 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Option Exercise | M | 14.39 | 2,150 | 30,939 | 2,150 | |
Dec 28 2018 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Sell | S | 82.53 | 2,150 | 177,440 | 19,160 | 21.3 K to 19.2 K (-10.09 %) |
Dec 28 2018 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Buy | M | 14.39 | 2,150 | 30,939 | 21,310 | 19.2 K to 21.3 K (+11.22 %) |
Sep 28 2018 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Option Exercise | M | 14.39 | 2,150 | 30,939 | 4,300 | |
Sep 28 2018 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Sell | S | 97.93 | 2,150 | 210,550 | 19,160 | 21.3 K to 19.2 K (-10.09 %) |
Sep 28 2018 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Buy | M | 14.39 | 2,150 | 30,939 | 21,310 | 19.2 K to 21.3 K (+11.22 %) |
Sep 27 2018 | STRO | SUTRO BIOPHARMA IN ... | LAWLIS V BRYAN | Director | Option Exercise | A | 15.00 | 26,033 | 390,495 | 26,033 | |
Jul 17 2018 | AGLE | Aeglea BioTherapeu ... | LAWLIS V BRYAN | Director | Option Exercise | A | 8.78 | 36,800 | 323,104 | 36,800 | |
Jun 29 2018 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Option Exercise | M | 14.39 | 2,150 | 30,939 | 6,450 | |
Jun 29 2018 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Sell | S | 93.52 | 2,150 | 201,068 | 19,160 | 21.3 K to 19.2 K (-10.09 %) |
Jun 29 2018 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Buy | M | 14.39 | 2,150 | 30,939 | 21,310 | 19.2 K to 21.3 K (+11.22 %) |
Jun 07 2018 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Grant | A | 0.00 | 4,300 | 0 | 19,160 | 14.9 K to 19.2 K (+28.94 %) |
May 17 2018 | GERN | GERON CORP | LAWLIS V BRYAN | Director | Option Exercise | A | 3.43 | 70,000 | 240,100 | 70,000 | |
Apr 19 2018 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Option Exercise | M | 38.59 | 3,750 | 144,713 | 0 | |
Apr 19 2018 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Sell | S | 85.00 | 3,750 | 318,750 | 14,860 | 18.6 K to 14.9 K (-20.15 %) |
Apr 19 2018 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Buy | M | 38.59 | 3,750 | 144,713 | 18,610 | 14.9 K to 18.6 K (+25.24 %) |
Feb 05 2018 | CHRS | Coherus BioScience ... | LAWLIS V BRYAN | Director | Option Exercise | A | 10.05 | 20,000 | 201,000 | 20,000 | |
Jan 04 2018 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Option Exercise | M | 38.59 | 3,750 | 144,713 | 3,750 | |
Jan 04 2018 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Sell | S | 88.84 | 3,750 | 333,150 | 14,860 | 18.6 K to 14.9 K (-20.15 %) |
Jan 04 2018 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Buy | M | 38.59 | 3,750 | 144,713 | 18,610 | 14.9 K to 18.6 K (+25.24 %) |
Sep 19 2017 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Option Exercise | M | 38.59 | 3,750 | 144,713 | 7,500 | |
Sep 19 2017 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Sell | S | 91.26 | 3,750 | 342,225 | 15,910 | 19.7 K to 15.9 K (-19.07 %) |
Sep 19 2017 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Buy | M | 38.59 | 3,750 | 144,713 | 19,660 | 15.9 K to 19.7 K (+23.57 %) |
Jun 20 2017 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Option Exercise | M | 38.59 | 3,750 | 144,713 | 11,250 | |
Jun 20 2017 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Sell | S | 90.00 | 3,750 | 337,500 | 15,910 | 19.7 K to 15.9 K (-19.07 %) |
Jun 20 2017 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Buy | M | 38.59 | 3,750 | 144,713 | 19,660 | 15.9 K to 19.7 K (+23.57 %) |
Jun 08 2017 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Option Exercise | A | 89.60 | 4,910 | 439,936 | 4,910 | |
Jun 08 2017 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Grant | A | 0.00 | 2,050 | 0 | 15,910 | 13.9 K to 15.9 K (+14.79 %) |
May 19 2017 | CHRS | Coherus BioScience ... | LAWLIS V BRYAN | Director | Option Exercise | A | 23.80 | 20,000 | 476,000 | 20,000 | |
May 10 2017 | GERN | GERON CORP | LAWLIS V BRYAN | Director | Option Exercise | A | 2.63 | 50,000 | 131,500 | 50,000 | |
Nov 14 2016 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Option Exercise | M | 17.33 | 7,500 | 129,975 | 7,500 | |
Nov 14 2016 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Sell | S | 95.00 | 7,500 | 712,500 | 13,860 | 21.4 K to 13.9 K (-35.11 %) |
Nov 14 2016 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Buy | M | 17.33 | 7,500 | 129,975 | 21,360 | 13.9 K to 21.4 K (+54.11 %) |
Jul 28 2016 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Option Exercise | M | 17.33 | 1,100 | 19,063 | 15,000 | |
Jul 28 2016 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Sell | S | 95.39 | 1,100 | 104,927 | 13,860 | 15 K to 13.9 K (-7.35 %) |
Jul 28 2016 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Buy | M | 17.33 | 1,100 | 19,063 | 14,960 | 13.9 K to 15 K (+7.94 %) |
Jul 26 2016 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Option Exercise | M | 17.33 | 6,400 | 110,912 | 16,100 | |
Jul 26 2016 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Sell | S | 95.01 | 6,400 | 608,064 | 13,860 | 20.3 K to 13.9 K (-31.59 %) |
Jul 26 2016 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Buy | M | 17.33 | 6,400 | 110,912 | 20,260 | 13.9 K to 20.3 K (+46.18 %) |
Jun 21 2016 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Sell | S | 82.77 | 550 | 45,524 | 13,860 | 14.4 K to 13.9 K (-3.82 %) |
Jun 08 2016 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Option Exercise | A | 89.52 | 4,440 | 397,469 | 4,440 | |
Jun 08 2016 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Grant | A | 0.00 | 1,510 | 0 | 14,410 | 12.9 K to 14.4 K (+11.71 %) |
May 26 2016 | CHRS | Coherus BioScience ... | LAWLIS V BRYAN | Director | Option Exercise | A | 18.28 | 10,000 | 182,800 | 10,000 | |
May 19 2016 | GERN | GERON CORP | LAWLIS V BRYAN | Director | Option Exercise | A | 2.74 | 50,000 | 137,000 | 50,000 | |
Nov 18 2015 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Option Exercise | M | 17.33 | 7,500 | 129,975 | 22,500 | |
Nov 18 2015 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Buy | S | 107.27 | 7,500 | 804,530 | 11,850 | 4.4 K to 11.9 K (+172.41 %) |
Nov 18 2015 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Buy | M | 17.33 | 7,500 | 129,975 | 19,350 | 11.9 K to 19.4 K (+63.29 %) |
Nov 18 2015 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Sell | S | 104.26 | 1,050 | 109,468 | 11,850 | 12.9 K to 11.9 K (-8.14 %) |
Jun 18 2015 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Option Exercise | A | 122.27 | 3,300 | 403,491 | 3,300 | |
Jun 18 2015 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Grant | A | 0.00 | 1,100 | 0 | 12,900 | 11.8 K to 12.9 K (+9.32 %) |
May 19 2015 | GERN | GERON CORP | LAWLIS V BRYAN | Director | Option Exercise | A | 3.88 | 35,000 | 135,800 | 35,000 | |
Apr 03 2015 | CHRS | Coherus BioScience ... | LAWLIS V BRYAN | Director | Option Exercise | A | 29.00 | 25,000 | 725,000 | 25,000 | |
Apr 03 2015 | CHRS | Coherus BioScience ... | LAWLIS V BRYAN | Director | Option Exercise | A | 29.00 | 6,250 | 181,250 | 6,250 | |
Apr 03 2015 | CHRS | Coherus BioScience ... | LAWLIS V BRYAN | Director | Option Exercise | A | 29.00 | 20,000 | 580,000 | 20,000 | |
Apr 13 2006 | ARDM | ARADIGM CORP | LAWLIS V BRYAN | President | Option Exercise | A | 3.77 | 150,000 | 565,500 | 150,000 | |
Feb 24 2005 | ARDM | ARADIGM CORP | LAWLIS V BRYAN | President | Option Exercise | A | 1.18 | 250,000 | 295,000 | 250,000 | |
Mar 04 2004 | ARDM | ARADIGM CORP | LAWLIS V BRYAN | President | Option Exercise | A | 2.40 | 250,000 | 600,000 | 250,000 |
Page: 1